How can we best deliver solubility-challenged small molecules to the clinic?

How can companies avoid the risks of HPAPI containment and handling?

Can machine learning offer mass spectrometry a boost for drug discovery?

Power testing partnership, NASH breakthrough designation, and new CEO appointments. What’s new for pharma in business?

Sitting Down With... Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia.

Fujifilm Toyama's influenza treatment passes COVID-19 trial.

Exploring a new approach to treating IBS pain.

In what ways can the microbiome interact with oral medicines?

QC must evolve to meet progress in biopharmaceutical manufacturing.

Looking back at Trump’s tenure, and the potential implications of the US elections for pharma and the Affordable Health Act.